Media Pack
News

Current Edition

Volume 7 issue 1

Upcoming Events

 
 

Advertisement

 
news

Bayer backs out of Atara cell therapy deal

Dive Brief: Bayer plans stop developing cancer cell therapies with Atara Biotherapeutics, informing the California biotech company that it will terminate a researc...
22 May 2022 news Atara | Bayer
Continue Reading →
news

Novartis turns cell therapy skill into contract manufacturing deal

Dive Brief: Novartis will manufacture an experimental cancer cell therapy for the small Philadelphia-based Carisma Therapeutics in a deal that marks another early ...
14 March 2022 news cell | contract
Continue Reading →
news

UCB to buy Zogenix for nearly $2B in ‘first step’ for M&A in 2022

Belgium's UCB on Wednesday said it has agreed to acquire Zogenix for as much as $1.9 billion in a deal centered around an epilepsy drug the California-based biotech b...
20 January 2022 news deal | Dravet syndrome
Continue Reading →
news

Daiichi acquires another ADC drug through Glycotope licensing deal

Daiichi Sankyo is bringing a seventh antibody-drug conjugate, or ADC, into its pipeline through a licensing agreement with German biotech Glycotope. Specific fin...
31 July 2018 news acquires | ADC
Continue Reading →
news

Merck inks deal with China’s Xian Janssen for type 2 diabetes drug

China has more than 114 million people living with diabetes, the largest number of any country in the world Global drug giant, Merck signed an agreement with Chi...
13 July 2018 news 2 | China's Xian
Continue Reading →
news

Nuance enters $58 M deal for non-opioid pain treatment in China

EXPAREL is a non-opioid option for achieving long-lasting pain control after surgery via infiltration into the surgical site or administration as an interscalene brac...
22 June 2018 news $58M | china
Continue Reading →
news

Lilly strikes $1.6B deal to buy I-O player Armo Biosciences

Eli Lilly and Co. said it will buy Armo Biosciences Inc. for about $1.6 billion, in an all-cash transaction intended to bolster its immuno-oncology program through th...
11 May 2018 news 1.6B | Armo
Continue Reading →
news

Cellmid inks deal with China’s Fukangren Bio-pharm

The deal aims to distribute Cellmid's évolis and anti-aging hair care products in the Peoples Republic of China Australia based Cellmid has recently announced that ...
4 May 2018 news Bio-pharm | Cellmid
Continue Reading →
 
IBI-white.png

International Biopharmaceutical Industry

IBI – International Biopharmaceutical Industry was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally.

Facebook Linkedin
Bio Pharmaceutical Media © 2024, All Rights Reserved – Powered by Teksyte